Dr. Rumey Ishizawar’s Research Finds Rheumatoid Arthritis Patients May Safely Receive Immune Checkpoint Inhibitors for Cancer Treatment
April 18, 2023
The study evaluated whether pre-existing rheumatoid arthritis was associated with a higher mortality and risk for immune-related adverse events with immune checkpoint inhibitor use. Joining Dr. Ishizawar in conducting this research were UNC colleagues; Dr. Amanda Lusa, Dr. Todd Schwartz, Carolina Alvarez, and Shruti Saxena Beem. Learn more about the...